SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-20-016440
Filing Date
2020-02-11
Accepted
2020-02-11 16:44:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv0134-g1therapeuticsinc.htm SC 13G 12143
  Complete submission text file 0001104659-20-016440.txt   13772
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

IRS No.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90214 | Film No.: 20597424
SIC: 2834 Pharmaceutical Preparations